In support of this, Harismendy et al[35] found that CAD risk SNPs altered the sequence of an enhancer element within the 9p21.3 risk locus and disrupted long-range physical interactions between the enhancer and the CDKN2A/B locus. Here, CDKN2A is linked to coronary artery disorder.